Frontlight ResearchEarly access
Trial site
Minnesota Oncology Hematology, P.A.
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Endometrial cancer2 trials
- Kidney cancer2 trials
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Completed1 trial
- Withdrawn1 trial
- Lead sponsor
- Pfizer3 trials
- Faeth Therapeutics1 trial
- Jazz Pharmaceuticals1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- Werewolf Therapeutics, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026